1. Home
  2. CTS vs ABCL Comparison

CTS vs ABCL Comparison

Compare CTS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • ABCL
  • Stock Information
  • Founded
  • CTS 1896
  • ABCL 2012
  • Country
  • CTS United States
  • ABCL Canada
  • Employees
  • CTS N/A
  • ABCL N/A
  • Industry
  • CTS Electrical Products
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTS Technology
  • ABCL Health Care
  • Exchange
  • CTS Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CTS 1.1B
  • ABCL 1.1B
  • IPO Year
  • CTS N/A
  • ABCL 2020
  • Fundamental
  • Price
  • CTS $39.18
  • ABCL $4.25
  • Analyst Decision
  • CTS
  • ABCL Strong Buy
  • Analyst Count
  • CTS 0
  • ABCL 5
  • Target Price
  • CTS N/A
  • ABCL $8.00
  • AVG Volume (30 Days)
  • CTS 265.1K
  • ABCL 7.0M
  • Earning Date
  • CTS 07-24-2025
  • ABCL 08-07-2025
  • Dividend Yield
  • CTS 0.41%
  • ABCL N/A
  • EPS Growth
  • CTS 18.55
  • ABCL N/A
  • EPS
  • CTS 2.11
  • ABCL N/A
  • Revenue
  • CTS $520,937,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • CTS $3.90
  • ABCL N/A
  • Revenue Next Year
  • CTS $6.50
  • ABCL $71.11
  • P/E Ratio
  • CTS $18.53
  • ABCL N/A
  • Revenue Growth
  • CTS 1.12
  • ABCL N/A
  • 52 Week Low
  • CTS $34.02
  • ABCL $1.89
  • 52 Week High
  • CTS $59.68
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • CTS 40.36
  • ABCL 50.33
  • Support Level
  • CTS $38.32
  • ABCL $4.13
  • Resistance Level
  • CTS $39.35
  • ABCL $4.41
  • Average True Range (ATR)
  • CTS 1.17
  • ABCL 0.34
  • MACD
  • CTS -0.19
  • ABCL -0.12
  • Stochastic Oscillator
  • CTS 20.61
  • ABCL 21.83

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: